Excessive use of steroid hormone & beneficial effects of True ST. 36 acupuncture on malignant brain tumors - Part I; how to estimate non-invasively presence of excess dose of steroid hormone in patients, baseball players & other professional athletes from its toxic effects on heart & pancreas, as well as persistent or recurrent infection - Part II

Acupuncture and Electro-Therapeutics Research

Volumn 30, Issue 1-2, 2005, Pages 57-102

  Omura, Yoshiaki ^a,b,c,d  

^a Heart Disease   (Bangladesh)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c International College of Acupuncture and Electro Therapeutics   (United States)

^d BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Baseball Players; Competitive Athletics; Decadron; Heart and Pancreas; Hyperglycemia; Malignant Brain Tumors (Anaplastic Astrocytoma and Glioblastoma Multiforme); Muscle Builders; Steroid Hormone

Indexed keywords

4 HYDROXYBUTYRIC ACID; 8 HYDROXYDEOXYGUANOSINE; ADRENALIN; AMPHETAMINE; ANDROSTANOLONE; ANDROSTENEDIONE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; BETA HYDROXY BETA METHYLBUTYRATE; BETAMETHASONE; CHOLESTEROL; CLENBUTEROL; DEXAMETHASONE; DOPAMINE; EPHEDRINE; ESTRADIOL; FOLIC ACID; GESTRINONE; IMMUNOGLOBULIN; METHAMPHETAMINE; METHYLPREDNISOLONE; PRASTERONE; PREDNISOLONE; STEROID HORMONE; TESTOSTERONE; TETRAHYDROGESTRINONE; THROMBOXANE B2; TRENBOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUPUNCTURE; AGGRESSION; ANXIETY; ARTERIOSCLEROSIS; ARTICLE; BI DIGITAL O RING TEST RESONANCE PHENOMENA; BRAIN CANCER; BREAST ATROPHY; BREAST HYPERTROPHY; CANCER CELL; CATARACT; CORONARY ARTERY DISEASE; DEPRESSION; DIZZINESS; DRUG STRUCTURE; EXCITABILITY; FEVER; FLUID RETENTION; GLAUCOMA; HAIR LOSS; HEADACHE; HEART DISEASE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HORMONE DETERMINATION; HUMAN; INFECTION CONTROL; KIDNEY CANCER; KIDNEY DISEASE; LIVER CANCER; LIVER INJURY; MANIA; MENSTRUATION DISORDER; MENTAL DISEASE; MOOD DISORDER; MUSCLE ATROPHY; NAUSEA; OSTEOPOROSIS; PANCREAS DISEASE; PERSISTENT INFECTION; PHOTOGRAPHY; RECURRENT INFECTION; SCREENING; SPORT; STROKE; TELOMERE; TESTIS ATROPHY;

EID: 24144490835     PISSN: 03601293     EISSN: None     Source Type: Journal    
DOI: 10.3727/036012905815901398     Document Type: Article

References (107)

1. Timothy E. Oaks, MD, Thomas Wannenberg, MD, Sherry A. Close, BSN, Laura E. Tuttle, BSN, and Neal D. Kon, MD. "Steroid-Free Maintenance Immunosuppression After Heart Transplantation". Presented at the forty-seventh annual meeting of southern thoracic surgical association, Marco Island, FL, Nov 9-11, 2000.
2. Taylor DO, Bristow MR, O'Connell JB, et al. "Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroids therapy". Journal of Heart and Lung Transplant. Vol. 15, pages 1039-1046, 1996.
3. Young RD, Steinhardt MA. "The Importance of physical fitness for the reduction of coronary artery disease risk factors". Sports Medicine. Vol. 19, pages 303-310, 1995.
4. McNutt RA, Ferenchick GS, Kirlin PC, et al. "Acute myocardial infarction in a 22-year-old world-class weight lifter using anabolic steroids". American Journal of Cardiology. Vol. 62, page 164, 1988.
5. Zuliani B, Bernardini A, Catapano M, et al. "Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders". International Journal of Sports Medicine, vol. 10, pages 62-66, 1988.
6. Katz MR, Barnhart GR, Szentpetery S, et al. "Are steroids essential for successful maintenance of immunosuppression in heart transplantation?". Journal of Heart and Lung Transplant. Vol. 6, pages 293-297, 1987.
7. Smart FW, Naftel DC, Costanzo MR, et al. "Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study". Journal of Heart and Lung Transplant. Vol. 15, pages 329-341, 1996.
8. Corrigan AB. "Dehydroepiandrosterone and sport." Medical Journal of Australia, Vol. 171, pages 206-208, 1999.
9. Wallace MB, Lim LA, Cutler A, Bucci L. "Effects of dehydroepianodrosterone vs androstenedione supplementation in men." Medicine & Science in Sports & Exercise, Vol. 31, pages 1788-1792, 1999.
10. Yesalis CE. "Medical, legal, and social implications of androstenedione use." Journal of the American Medical Association. Vol. 281, pages 2043-2044, 1999.
11. King DS, Sharp RL, Vukovich MD, et al. "Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men." Journal of the American Medical Association, Vol. 281, pages 2020-2028, 1999.
12. Leder BZ, Longscope C, Catlin DH, et al. "Oral androstenedione administration and serum testosterone concentrations in young men." Journal of the American Medical Association. Vol. 283, pages 779-782, 2000.
13. Bowers, LD. "Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio." Clinical Chemistry. Vol. 45, pages 295-297, 1999.
14. Kicman AT, Coutta SB, Walker CJ, Cowan DA. "Proposed confirmatory procedure for detecting 5 alpha-dihydrotestosterone doping in male athletes." Clinical Chemistry. Vol. 41, pages 1617-1627, 1995.
15. Muscling in on clenbuterol [editorial]. Lancet, Vol. 340, page 403, 1992.
16. Prather ID, Brown DE, North P, Wilson JR. "Clenbuterol: a substitute for anabolic steroids?" Medicine & Science in Sports & Exercise. Vol. 27, pages 1118-1121, 1995.
17. American College of Sports Medicine. "The use of blood doping as an ergogenic aid." Medicine & Science in Sports & Exercise, Vol. 28, pages 1-8, 1996.
18. Ekblom B. "Blood doping and erythropoietin, the effects of variation in haemoglobin concentration and other related factors on physical performance." American Journal of Sports Medicine. Vol. 24 (6 Suppl), pages S40-42, 1996.
19. Gareau R, Audran M, Baynes RD, et al. "Erythropoietin abuse in athletes." Nature. Vol. 380, page 113, 1996.
20. Willey WJ. "Insulin as an anabolic aid? A danger for strength athletes." Physician and Sports Medicine. Vol. 25, pages 103-104, 1997.
21. Dawson RT, Harrison MW. "Use of insulin as an anabolic agent." British Journal of Sports Medicine. Vol. 31, page 259, 1997.
22. Council on Scientific Affairs. "Drug abuse in athletes. Anabolic steroids and human growth hormone." Journal of the American Medical Association. Vol. 259, pages 1703-1705, 1988.
23. Yarasheski KE, Zachwieja JJ, Angleopoulos TJ, Bier DM. "Short-term growth hormone does not increase muscle protein synthesis in experienced weight lifters." Journal of Applied Physiology. Vol. 74, pages 3073-3076, 1993.
24. Taaffe DR, Pruitt L, Reim J, et al. "Effect of recombinant human growth hormone on the muscle strength response on resistance exercise in elderly men." Journal of Clinical Endocrinology & Metabolism. Vol. 79, pages 1361-1366, 1994.
25. Crist DM, Peake GT, Egan PA, Waters DA. "Body composition response to exogenous GH during training in highly conditioned adults." Journal of Applied Physiology. Vol. 65, pages 579-584, 1988.
26. Wu Z, Bidlingmaier M, Dall R, Strasburger CJ. "Detection of doping with growth hormone." Lancet. Vol. 353, page 895, 1999.
27. Bach LA. "The insulin-like growth factor system: Basic and clinical aspects." Australian and New Zealand Journal of Medicine. Vol. 29, pages 355-361, 1999.
28. Nissen S, Sharp R, Ray JA, et al. "Effect of leucine metabolite β-hydroxy-β-methylbutyrate on muscle metabolism during resistance-exercise training." Journal of Applied Physiology. Vol. 81, pages 2095-2104, 1996.
29. Kennedy, Michael C. "Newer drugs used to enhance sporting performance." Medical Journal of Australia. Vol. 173, pages 314-317, 2000.
30. Narducci WA, Wagner JC, Hendrickson TP, et al. "Anabolic steroids: a review of the clinical toxicology and diagnostic screening." Journal of Toxicology & Clinical Toxicology. Vol. 28(3), pages 287-310, 1990.
31. U.S. Department of Justice. "Steroid Abuse in Today's Society: A Guide for Understanding Steroids and Related Substances." Drug Enforcement Administration Office of Diversion Control, 2004.
32. Micromedex. "PDR Drug Information for Decadron Tablets." Drug Information Online, 2005.
33. Ruibal, Sal. "Steroid Case Takes On New Life." USA Today, page C1, 2004.
34. Johansson P, Hallberg M, Kindlundh AMS, Nyberg F. "The Effect On Opioid Peptides In The Rat Brain, After Chronic Treatment With The Anabolic Androgenic Steroid, Nandrolone Decanoate." Brain Research Bulletin. Vol. 51(5), pages 413-418, 2000.
35. Hallberg M, Johansson P, Kindlundh AMS, Nyberg F. "Anabolic- Androgenic Steroids Affect The Content Of Substance P And Substance P(1-7) In The Rat Brain." Peptides. Vol. 21(6), pages 845-852, 2000.
36. Sader MA, Griffiths KA, McCredie RJ, Handelsman DJ, Celermajer DS. "Androgenic Anabolic Steroids And Arterial Structure And Function In Male Bodybuilders." Journal of the American College of Cardiology. Vol. 37(1), pages 224-230, 2001.
37. Palatini P, Giada F, Garavelli G, Sinisi F, Mario L, Michieletto M, Baldo-Enzi G. "Cardiovascular Effects Of Anabolic Steroids In Weight-Trained Subjects." Journal of Clinical Pharmacology. Vol. 36(12), pages 1132-1140, 1996.
38. Dickinson B, Goldberg L, Elliot D, Spratt D, Rogol AD, Fish LH. "Hormone Abuse In Adolescents And Adults: A Review Of Current Knowledge." The Endocrinologist. Vol. 15(2), pages 115-125, 2005.
39. Stimac D, Milic S, Dintinjana RD, Kovac D, Ristic S. "Androgenic/ Anabolic Steroid-Induced Toxic Hepatitis. Journal of Clinical Gastroenterology, Vol. 35(4), pages 350-352, 2002.
40. Kuipers H. "Anabolic Steroids: Side Effects." Encyclopedia of Sports Medicine and Science, 1998.
41. Roomi MW. "Vitamin C and Cancer." The Linus Pauling Institute, 2003.
42. Thorne Research. "Many potential benefits of DHEA for youthfulness and healthy life." Alternative Medicine Review, Vol. 6(3), pages 314-318, 2001.
43. Bonaa KH, Bjerve KS, Nordoy A. "Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans." Arteriosclerosis Thrombosis. Vol. 12(6), pages 6750681, 1992.
44. Tawakol A, Migrino RQ, Aziz KS, Waitkowska J, Holmvang G, Alpert NM, Muller JE, Fischman AJ, Gewirtz H. "High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease." Journal of the American College of Cardiology. Vol. 45(10), pages 1580-1584, 2005.
45. Johnstone JF, Bocking AD, Unlugedik E, Challis JR. "The effects of chorioamnionitis and betamethasone on 11beta hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor in preterm human placenta." Journal of the Society for Gynecologic Investigation. Vol. 12(4), pages 238-245, 2005.
46. Serrano-Mollar A, Closa D. "Arachidonic Acid Signaling in Pathogenesis of Allergy: Therapeutic Implications." Current Drug Targets-Inflammation & Allergy, Vol. 4(2), pages 151-155, 2005.
47. Basaria S, Dobs AS. "New modalities of transdermal testosterone replacement." Treatments in Endocrinology. Vol. 2(1), pages 1-9, 2003.
48. Nakao A, Iwagaki H, Notohara K, Morimoto Y, Ariki N, Kanagawa T, Isozaki H, Tanaka H. "Successful resection of rectal carcinoma in an Evans' syndrome patient followed by predonisolone and high-dose immunoglobulin: report of a case." Acta Medica Okayama, Vol. 55(4), pages 253-257, 2001.
49. Zivadinov R. "Steroids and brain atrophy in multiple sclerosis." Journal of the Neurological Sciences, 2005.
50. Ritter S. "Designer Steroid Rocks Sports World: UCLA chemists identify steroid purportedly designed to avoid detection in routine tests." Science & Technology, Vol. 81(46), pages 66-69, 2003.
51. Anderson RG. "Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology." Trends in Cell Biology, Vol. 13, pages 534-539, 2003.
52. Ockene IS, Chiriboga DE, Stanek EJ, Harmatz MG, Nicolosi R, Saperia G, Well AD, Freedson P, Merriam PA, Reed G, Ma Y, Matthews CE, Hebert JR. "Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms." Archives of Internal Medicine, Vol. 164, pages 863-870, 2004.
53. Ahman S, Singh N, Glazer RI. "Role of AKT1 in 17beta-estradiol- and insulin-like growth factor 1 (IGF-1)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochemical Pharmacology, Vol. 58(3), pages 425-430, 1999.
54. Maltin CA, Delday MI, Hay SM, Smith FG, Lobley GE, Reeds PJ. "The effects of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle." Bioscience Reports. Vol. 7(2), pages 143-149, 1987.
55. Prather ID, Brown DE, North P, Wilson JR. "Clenbuterol: a substitute for anabolic steroids?" Medicine & Science in Sports & Exercise, Vol. 27(8), pages 1118-1121, 1995.
56. Su WJ, Perng RP. "Spiorpent (clenbuterol): another choice for patients with chronic irreversible airway obstructions." Chung Hua I Hsueh Tsa Chin (Taipei), Vol. 47(1), pages 13-17, 1991.
57. Bessman SP, Fishbein WN. "Gamma hydroxybutyrate, a normal brain metabolite." Nature, Vol. 200, pages 1207-1208, 1963.
58. Mamelak M. "Gammahydroxybutyrate: An endogenous regulator of energy metabolism." Neuroscience and Behavioral Reviews. Vol. 13, pages 187-198, 1989.
59. Tunnicliff G. "Sites of action of gamma-hydroxybutyrate (GHB)-A neuroactive drug with abuse potential." Journal of Toxicology-Clinical Toxicology. Vol. 35, pages 581-590, 1997.
60. Nissen S, Sharp R, Ray M, Rathmacher JA, Rice D, Fuller JC, Connelly AS, Abumrad N. "Effect of Leucine Metabolite Beta-Hydroxy-Beta-Methylbutyrate on Muscle Metabolism During Resistance-Exercise Training." Journal of Applied Physiology. pages 2095-2104, 1996.
61. Nissen, Abumrad. "Nutritional role of the leucine metabolite β-hydroxy-β-methylbutyrate (HMB)." Journal of Nutritional Biochemistry. Vol. 8, pages 300-311, 1997.
62. Kreider RB. "Dietary supplements and the promotion of muscle growth with resistance exercise." Sports Medicine. Vol. 27(2), pages 97-110, 1999.
63. Bahrke MS, Yesalis CE, Wright JE. "Psychological and Behavioural Effects of Endogenous Testosterone Levels and Anabolic-Androgenic Steroids Among Males: A Review." Sports Medicine. Vol. 10(5), pages 303-337, 1990.
64. Kuiper G, Faber PW, van Rooij H, van der Korput J, Ris-Stalpers C, Klaassen P, Trapman J, Brinkmann AO. "Structural organization of the human androgen receptor gene." Journal of Molecular Endocrinology, Vol. 2, pages R1-R4, 1989.
65. Omura Y. "A new, simple, non-invasive imaging technique of internal organs and various cancer tissues using extended principles of the "Bi-Digital O-Ring Test" without using expensive imaging instruments or exposing the patient to any undesirable radiation - Part 1." Acupuncture & Electro-Therapeutics Research. The International Journal. Vol. 10, pages 255-277, 1985.
66. Omura Y. "Bi-Digital O-Ring Test Molecular Identification and Localization Method" and its application in imaging of internal organs and malignant tumors as well as identification and localization of neurotransmitters and micro-organisms - Part 1." Acupuncture & Electro-Therapeutics Research. The International Journal. Vol. 11(2), pages 65-100, 1986.
67. Omura Y. "Re-evaluation of the classical acupuncture concept of meridians in oriental medicine by the new method of detecting meridian-like networks connected to internal organs using "Bi-Digital O-Ring Test"." Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 11, pages 219-231, 1986.
68. Omura Y. "Electro-magnetic resonance phenomenon as a possible mechanism related to the "Bi-Digital O-Ring Test Molecular Identification and Localization Method." Acupuncture & Electro-Therapeutics Research. The International Journal. Vol. 11(2), pages 127-145, 1986.
69. Omura Y. "Meridian-like networks of internal organs, corresponding to traditional Chinese 12 main meridians and their acupuncture points as detected by the "Bi-Digital O-Ring Test Imaging Method:" Search for the corresponding internal organ of western medicine for each meridian - Part 1." Acupuncture & Electro-Therapeutics Research. The International Journal, Vol. 12, pages 53-70, 1987.
70. Omura Y. "Interrelationship between the heart and central nervous system: localization of neuro-transmitters and imaging of their associated nuclei, including the raphe nuclei & the locus coeruleus, as well as the imaging of the heart and its representation areas in slices of the human central nervous system using the "Bi-Digital O-Ring Test" imaging method." Acupuncture & Electro-Therapeutics Research. The International Journal, Vol. 12, pages 139-170, 1987.
71. Omura Y, Takeshige C, Shimotsuura Y, Suzuki M. "Imaging of the stomach and localization of the stomach meridian & its acupuncture points in a human cadaver by the use of the indirect "Bi-Digital O-Ring Test Imaging Technique"." Acupuncture & Electro-Therapeutics Research, The International Journal. Vol. 13, pages 153-164, 1988.
72. Omura Y. "Connections found between each meridian (heart, stomach, triple burner, etc.) & organ representation area of corresponding internal organs in each side of the cerebral cortex; release of common neurotransmitters and hormones unique to each meridian and corresponding acupuncture point & internal organ after acupuncture, electrical stimulation, mechanical stimulation (including shiatsu), soft laser stimulation or Qi Gong." Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 14, pages 155-186, 1989.
73. Omura Y. "Transmission of molecular information through electro-magnetic waves with different frequencies and its application to non-invasive diagnosis of patients as well as detection from patient's x-ray film of visible and not visible medical information: Part 1." Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 19(1), pages 39-63, 1994.
74. Omura Y, Shimotsuura Y, Ooki M, Noguchi T. "Estimation of the Amount of Telomere Molecules in Different Human Age Groups and the Telomere Increasing Effect of Acupuncture and Shiatsu on ST.36, Using Synthesized Basic Units of the Human Telomere Molecules as Reference Control Substances for the Bi-Digital O-Ring Test Resonance Phenomenon, Presented as a guest speaker at 8th Annual Congress of Japan Bi-Digital O-Ring Test Medical Society at Showa University, Tokyo." Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 23(3&4), pages 185-206, 1998.
75. Omura Y. "Transmission of Molecular Information on Molecular Structures and Amounts of the Molecules Through the Recorded Traces of Photons, Sound Waves, and Electric Currents Coming Through Biological Tissue and Their Clinical Applications For New Non-invasive Diagnosis and Treatment of Intractable Medical Problems, presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo." Acupuncture & Electro-Therapeutics Research. The International Journal. Vol. 26(1-2), pages 77-79, 2001.
76. Duvvi H, Omura Y. "Evaluation of the Bi-Digital O-Ring Test for the Detection of Precancer from Rat Colon Photographs, presented at the 16th Annual Symposium on Acupuncture and Electro Therapeutics, October 19-22, 2000, at the School of International Affairs at Columbia University." abstract published in Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 25(3-4), pages 249-250, 2000.
77. Omura Y, Tobe Y. "Marked Beneficial Effects Obtained After Acupuncture at True St. 36 Compared With Very Little Effects Obtained From Acupuncture On Traditional St. 36-Localization of True St. 36 & Traditional St. 36 and their Acupuncture Effects Clarified Using the Bi-Digital O-Ring Test." (in Japanese) Ido No Nippon (The Japanese Journal of Acupuncture & Manual Therapies), Serial No. 692, pages 129-150, Oct. 2001.
78. Omura Y. "2 Minute Screening of Cancer and Localization of the Cancer Using X-, Y-Axis Laser line Scanning of the Whole Body and Effective Treatment of Cancer using Selective Drug Uptake Enhancement Method Including Semi-Permanent Acupuncture on True St. 36, Which Markedly Reduces Cancer Cell Telomere and Enhances Normal Cell Telomere.", pgs. 122-127, Abstract of 5th Biennial International Symposium on Bi-Digital O-Ring Test, organized and published by Japan Bi-Digital O-Ring Test Medical Society, held at Ibuka International Auditorium, Waseda University, Tokyo, Japan, during July 19-21, 2002.
79. Jackson J, Gajewski E, Schraufstatter I, Hyslop P, Fuciarelli A, Cochrane, Dizdaroglu M. "Damage to the bases in DNA induced by stimulated human neutrophils." Journal of Clinical Investigation, Vol. 84(5), pages 1644-1649, 1989.
80. Lu J, Shi L, Wu Z, Liao Y, Zhou C, Li Y, Bin X, Zeng B, Chen J. "Study of 8-OH-dG and its correlation with several cancer related gene in lung cancer tissues." Wei Sheng Yan Jiu (Chinese journal), Vol. 32(4), pages 304-307, 2003.
81. Tsurudome Y, Hirano T, Hirata K, Higure A, Nagata N, Takahashi K, Itoh H, Kasai H. "Age-Associated Increase of 8-Hydroxydeoxyguanosine in Human Colorectal Tissue DNA." The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol. 56, pages B483-B485, 2001.
82. Kasai H. "Analysis of 8-hydroxydeoxyguanosine as a marker for oxidative stress, animal and human studies." Cancer Detection & Prevention. Vol. 24(Supplement 1), pages 101-103, Oct. 28-31 2000, Geneva, Switzerland.
83. Walters J. "Methamphetamine." ONDCP: Drug Policy Information Clearinghouse Fact Sheet, Nov. 2003.
84. nd ed. American Psychiatric Press, 1999.
85. Guze BH, Ferng HK, Szuba MP, Richeimer SH. The Psychiatric Drug Handbook, pages 184-260, 1995.
86. Dollery C, ed. "Therapeutic Drugs." Churchill Livingstone Inc. New York: 1991.
87. Astrup A, Toubro S. "Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man." International Journal of Obesity and Related Metabolic Disorders, Vol. 17(Suppl), pages S41-S43, 1993.
88. Roxanas MG, Spalding J. "Ephedrine abuse psychosis." Medical Journal of Australia, Vol. 2(19), pages 639-640, 1977.
89. Velasco M, Luchsinger A. "Dopamine: Pharmacologic and Therapeutic Aspects." American Journal of Therapeutics, Vol. 5(1), pages 37-43, 1998.
90. Threlkeld DS, ed. "Respiratory Drugs, Bronchodilators, Sympathomimetics." Facts and Comparisons Drug Information, page 177-a, 1994.
91. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology (5 ed), Edinburgh: Churchill Livingstone, 2003.
92. Cass Terry. "Clinical Guidelines for Use in Antiagine Medicine." Integrative Medical Therapeutics for Anti aging Conference (held September 11-13, 2004 at Miami Beach Convention Center), pages 443-472, 2004.
93. Omura Y, Losco M, Omura AK, Takeshige C, Hisamitsu T, Nakajima H, Soejima K, Yamamoto S, Ishikawa H, Kagoshima T, Watari N, Shimotsuura Y, Matsubara T. "Bi-Directional Transmission of Molecular Information by Photon or Electron Beams Passing in the Close Vicinity of Specific Molecules, and its Clinical and Basic Research Applications: 1) Diagnosis of Humans or Animal Patients Without Any Direct Contact; 2) Light Microscope and Electron Microscope Localization of Neurotransmitters, Heavy Metals, Oncogen C-fos (AB2), etc. of Intracellular Fine Structures of Normal and Abnormal Single Cells Using Light or Electro-Microscopic Indirect Bi-Digital O-Ring Test." Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 17, pages 29-46, 1992.
94. Hagen TM, Ingersoll RT, Lykkesfeldt J, et al. "(R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate." FASEB Journal. Vol. 13, pages 411-418, 1999.
95. Natrej CV, Gandhi VM, Melon KKG. "Lipoic acid and diabetes: effect of dihydrolipoic acid administration in diabetic rats and rabbits." Journal of Biosciences, Vol. 6, pages 37-46, 1984.
96. Nickander KK, McPhee BR, Low PA, Tritschler H. "Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy." Free Radical Biology & Medicine. Vol. 21, pages 631-639, 1996.
97. Packer L, Tritschler HJ, Wessel K. "Neuroprotection by the metabolic antioxidant alpha-lipoic acid." Free Radical Biology & Medicine. Vol. 22, pages 359-378, 1997.
98. Packer L, Witt EH, Tritschler HJ. "Alpha-lipoic as a biological antioxidant." Free Radical Biology & Medicine, Vol. 19, pages 227-250, 1995.
99. Reed LJ. "The chemistry and function of lipoic acids." Advances in Enzymology, Vol. 18, pages 319-347, 1957.
100. Wagh SS, Natraj CV, Menon KKG. "Mode of action of lipoic acid in diabetes." Journal of Biosciences, Vol. 11, pages 59-74, 1987.
101. Chuang WW, Lin WW, Lamb DJ, Lipshultz LI. "Effect of acetylcarnitine on sperm motility." Journal of Urology, Vol. 163(4 Suppl), Abstract 1324, 2000.
102. Lolic MM, Fiskum G, Rosenthal RE. "Neuroprotective effects of acetyl-L-carnitine after stroke in rats." Annals of Emergency Medicine, Vol. 29, pages 758-765, 1997.
103. Onofrj M, Fulgente T, Melchiadona D, et al. "L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain." International Journal of Clinical Pharmacology Research (Geneva), Vol. 15, pages 9-15, 1995.
104. Pettegrew JW, Klunke WE, Panchalingam K. "Clinical and biochemical effects of acetyl-L-carnitine in Alzheimer's disease." Neurobiology of Aging, Vol. 16, pages 1-4, 1995.
105. Salvioli G, Neri M. "L-acetylcarnitine treatment of mental decline in the elderly." Drugs Under Experimental and Clinical Research, Vol. 20, pages 169-176, 1994.
106. Biewenga GP, Haenen GR, Bast A. "The pharmacology of the antioxidant lipoic acid." General Pharmacology, Vol. 29(3), pages 315-331, 1997.
107. Packer L, Kraemer K, Rimbach G. "Molecular aspects of lipoic acid in the prevention of diabetes complications." Nutrition. Vol. 17(10), pages 888-895, 2001.